Enzon Pharmaceuticals, Inc. (ENZN)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.4100

+0.0200

(+5.13%)

As of 10:03AM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.3900
Open	0.4059
Bid	0.3800 x 3000
Ask	1.4100 x 200
Day's Range	0.4059 - 0.4100
52 Week Range	0.2400 - 0.4900
Volume	9,060
Avg. Volume	48,135

Market Cap	30.428M
Beta (5Y Monthly)	0.04
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0380
Earnings Date	Aug 04, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Sep 30, 2019
1y Target Est	14.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ENZN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

ENZON PHARMACEUTICALS INC
Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
Rating
Fair Value
Economic Moat
yesterdayArgus Research